Nitrogen

Description

Nitrogen Refrigerated Liquid N.F. is classified as a non-flammable gas under UN 1977. The product is supplied in a pressurized container, with specific gross and net weights, as well as a defined size and contents measured in liters. It is imperative to maintain the container in an upright position at all times.

This substance is extremely cold and can cause rapid suffocation and severe frostbite upon contact. It is essential to utilize equipment specifically designed for nitrogen service and rated for cylinder pressure. Direct contact with the liquid should be avoided; protective gear, including a face shield and gloves, is recommended during liquid withdrawal. The container should not be dropped, and a hand truck designed for liquid cylinder movement should be used. The valve must be closed after each use and when the container is empty, and all handling should comply with the Material Safety Data Sheet (MSDS).

Ventilation is critical; cylinders should not be vented in confined spaces, and entry into such areas should only occur after ensuring adequate ventilation and oxygen levels (minimum 19%) using an approved oxygen measuring instrument or while wearing an approved air-supplied breathing apparatus, with a second person similarly equipped. This product is available by prescription only, as federal law prohibits dispensing without a valid prescription.

Uses and Indications

This drug is indicated for use in specific medical applications as determined by healthcare professionals. However, the document does not provide specific indications or usage details for Nitrogen Refrigerated Liquid.

There are no reported teratogenic effects associated with this drug, nor are there any documented nonteratogenic effects. Healthcare providers should consider these factors when evaluating the use of this drug in patient care.

Dosage and Administration

Administration of the product should be conducted in an upright position to ensure optimal delivery. It is imperative that only equipment designated for nitrogen service and rated for cylinder pressure is utilized during administration. The valve must be closed after each use to maintain safety and integrity of the system. If the valve is equipped with a protective cap, it should be kept in place when the product is not in use.

Healthcare professionals are advised to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) during administration. The product should be returned with a pressure of 25 PSIG to ensure proper handling and safety.

The route of administration is via respiratory inhalation. Administration should be performed under the supervision of a licensed practitioner who is experienced in the use and administration of nitrogen.

Contraindications

Administration of nitrogen is contraindicated in patients who are not under the supervision of a licensed practitioner experienced in its use. Due to the potential hazards associated with nitrogen, it is essential that only qualified healthcare professionals administer this substance, as they must be familiar with its indications, effects, dosages, methods, frequency, duration of administration, and associated risks.

Liquid nitrogen must not come into contact with eyes, skin, or clothing. Additionally, nitrogen cylinders should not be vented in confined spaces. Entry into confined spaces where nitrogen gas may be present is contraindicated unless the area has been adequately ventilated and tested for sufficient oxygen levels (minimum 19%) using an approved oxygen measuring instrument. If necessary, personnel should wear an approved air-supplied breathing apparatus and have a second person present with similar equipment.

Furthermore, the removal of the product label is prohibited, and care should be taken to avoid dropping the cylinder. Federal law mandates that nitrogen can only be dispensed with a prescription.

Warnings and Precautions

Caution must be exercised when handling high-pressure gas, as it poses a risk of rapid suffocation. It is imperative to store and use nitrogen in well-ventilated areas. Users are required to secure the cylinder both during use and while in storage to prevent accidents.

In accordance with federal regulations, the dispensing of nitrogen is prohibited without a valid prescription.

The administration of nitrogen may present hazards or be contraindicated in certain situations. It is essential that nitrogen is used solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

In the event of inhalation, immediate action is required. The affected individual should be removed to an area with fresh air. If the individual is not breathing, artificial respiration should be administered. If breathing difficulties arise, supplemental oxygen should be provided. It is crucial to contact a physician for further evaluation and management.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of nitrogen. High-pressure gas can pose significant risks, including the possibility of rapid suffocation. Therefore, it is crucial to store and use nitrogen with adequate ventilation. Users are advised to secure the cylinder both during use and in storage to prevent accidents.

The administration of nitrogen may be hazardous or contraindicated in certain situations. It is imperative that nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

The drug has not been established as safe and effective for pediatric patients, and this labeling has not received FDA approval.

Administration of nitrogen may pose hazards or be contraindicated in this population. It is essential that the drug be used only by or under the supervision of a licensed practitioner who has experience in the use and administration of nitrogen.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of nitrogen is contraindicated in pregnancy due to potential risks to fetal outcomes. The use of nitrogen should be limited to situations where it is administered by or under the supervision of a licensed practitioner experienced in its use and administration. Pregnant patients should be advised against exposure to nitrogen, as its administration may pose hazards that could adversely affect both maternal and fetal health. It is essential for healthcare professionals to consider these factors when treating women of childbearing potential and to explore alternative therapies that are safer during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Consequently, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the available data. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the lack of information necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to always use the product in an upright position and only with equipment designated for nitrogen service that is rated for cylinder pressure. It is essential to close the valve after each use and to keep the valve protective cap in place when not in use, if so equipped. Patients should be instructed to use the product in accordance with the Material Safety Data Sheet (MSDS) and to return the cylinder with a pressure of 25 PSIG.

Providers must emphasize the importance of not removing the product label and ensuring that the container is always kept in an upright position. Patients should be made aware of the warning regarding the extremely cold liquid and gas under pressure, which can cause rapid suffocation and severe frostbite. They should be cautioned against getting the liquid in their eyes, on their skin, or on their clothing. For liquid withdrawal, it is critical that patients wear a face shield and gloves.

Healthcare providers should instruct patients not to drop the cylinder and to use a hand truck specifically designed for liquid cylinder movement. They must also remind patients to close the valve after each use and when the cylinder is empty. It is important to reiterate that the product should not be vented in confined spaces and that patients should not enter confined spaces where gas may be present unless the area has been well-ventilated and tested for adequate oxygen levels (at least 19%) with an approved oxygen measuring instrument or while wearing an approved air-supplied breathing apparatus, with a second person present who is similarly equipped.

Providers should inform patients that this product is available by prescription only, as federal law prohibits dispensing without a prescription. They must caution that high-pressure gas can cause rapid suffocation and that the cylinder should be stored and used with adequate ventilation. Patients should be advised to secure the cylinder both in use and in storage.

Finally, healthcare providers should communicate that the administration of nitrogen may be hazardous or contraindicated and is to be used only by or under the supervision of a licensed practitioner experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the hazards, contraindications, side effects, and necessary precautions. In case of inhalation, patients should be instructed to remove themselves to fresh air, provide artificial respiration if not breathing, administer oxygen if breathing is difficult, and call a physician.

Storage and Handling

The product is supplied in a cylinder that must be used in an upright position. It is essential to utilize equipment specifically designated for nitrogen service and rated for cylinder pressure. After each use, the valve should be closed, and if the cylinder is equipped with a protective cap, it must be kept in place when not in use.

For safety during liquid withdrawal, users are required to wear a face shield and gloves. The cylinder should never be dropped; instead, a hand truck designed for liquid cylinder movement should be employed. Adequate ventilation is necessary during both storage and use of the cylinder.

Users must secure the cylinder both in use and during storage. It is critical to avoid venting the cylinder in confined spaces. Additionally, entry into confined spaces where gas may be present is prohibited unless the area has been adequately ventilated and tested for sufficient oxygen levels (at least 19%) using an approved oxygen measuring instrument. Alternatively, an approved air-supplied breathing apparatus must be worn, with a second person present who is similarly equipped.

Additional Clinical Information

Patients should be aware that the route of administration for this treatment is via respiratory inhalation. It is crucial that nitrogen is administered only by or under the supervision of a licensed practitioner who is experienced in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Compressed Gases Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)